Long Term Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for MS
- Study Title
- A Study to Evaluate the Long Term Safety and Effectiveness of Novantrone Therapy Followed by Copaxone Treatment for Multiple Sclerosis
- Teva Identifier
- PM025
- ClinicalTrials.gov Identifier
- NCT00203086
- Study Status
- Completed
- Trial Condition(s)
- Relapsing Remitting Multiple Sclerosis
- Interventions
- Drug: Copaxoneֲ®
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult
- Age Range
- 20 Years to 57 Years
- Trial Duration
- 10/01/2005 - 12/01/2009
